Tumor-promoting function and regulatory landscape of PD-L2 in B-cell lymphoma

Leukemia. 2023 Feb;37(2):492-496. doi: 10.1038/s41375-022-01772-1. Epub 2022 Dec 15.

Sumito Shingaki^#¹, Junji Koya^#¹, Mitsuhiro Yuasa^#^{1

2}, Yuki Saito^{1

3}, Mariko Tabata^{1

4}, Marni B McClure¹, Seishi Ogawa^{5

6

7}, Kotoe Katayama⁸, Yosuke Togashi⁹, Seiya Imoto¹⁰, Yasunori Kogure¹, Keisuke Kataoka^{11

12}

¹ Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
² Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
³ Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan.
⁴ Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
⁵ Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁶ Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.
⁷ Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.
⁸ Laboratory of Sequence Analysis, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
⁹ Department of Tumor Microenvironment, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
¹⁰ Division of Health Medical Intelligence, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
¹¹ Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan. kkataoka-tky@umin.ac.jp.
¹² Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. kkataoka-tky@umin.ac.jp.

^# Contributed equally.

No abstract available

Publication types